Systemic sclerosis-associated interstitial lung disease.
Perelas A, Silver RM, Arrossi AV, Highland KB.
Lancet Respir Med. 2020 Mar;8(3):304-320. doi: 10.1016/S2213-2600(19)30480-1. Epub 2020 Feb 27.
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions.
Liakouli V, Ciancio A, Del Galdo F, Giacomelli R, Ciccia F.
Nat Rev Rheumatol. 2024 Jan;20(1):21-32. doi: 10.1038/s41584-023-01044-x. Epub 2023 Nov 3.
Current advances in the treatment of systemic sclerosis.
Bukiri H, Volkmann ER.
Curr Opin Pharmacol. 2022 Jun;64:102211. doi: 10.1016/j.coph.2022.102211. Epub 2022 Apr 18.
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.
Khanna D, Tashkin DP, Denton CP, Renzoni EA, Desai SR, Varga J.
Am J Respir Crit Care Med. 2020 Mar 15;201(6):650-660. doi: 10.1164/rccm.201903-0563CI.
Identification and management of interstitial lung disease associated with systemic sclerosis (SSc-ILD), rheumatoid arthritis (RA-ILD), and polymyositis/dermatomyositis (PM/DM-ILD): development of expert consensus-based clinical algorithms.
Kondoh Y, Bando M, Kawahito Y, Sato S, Suda T, Kuwana M.
Expert Rev Respir Med. 2024 Jun;18(6):447-456. doi: 10.1080/17476348.2024.2374910. Epub 2024 Jul 15.
Interstitial lung disease in connective tissue disorders.
Fischer A, du Bois R.
Lancet. 2012 Aug 18;380(9842):689-98. doi: 10.1016/S0140-6736(12)61079-4.
Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease.
Mulcaire-Jones E, Pugashetti JV, Oldham JM, Khanna D.
Semin Respir Crit Care Med. 2024 Jun;45(3):435-448. doi: 10.1055/s-0044-1786155. Epub 2024 May 13.
Nerandomilast Improves Bleomycin-Induced Systemic Sclerosis-Associated Interstitial Lung Disease in Mice by Regulating the TGF-beta1 Pathway.
Liu Y, Liu Z, Li X, Li W, Yang Z, Jiao R, Wang Q, Meng L, Zhang T, Liu J, Chai D, Zhang N, Peng S, Zhou H, Yang C.
Inflammation. 2025 Aug;48(4):1760-1774. doi: 10.1007/s10753-024-02153-9. Epub 2024 Oct 23.
Scleroderma lung disease.
Solomon JJ, Olson AL, Fischer A, Bull T, Brown KK, Raghu G.
Eur Respir Rev. 2013 Mar 1;22(127):6-19. doi: 10.1183/09059180.00005512.
Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease.
Valenzi E, Tabib T, Papazoglou A, Sembrat J, Trejo Bittar HE, Rojas M, Lafyatis R.
Front Immunol. 2021 Mar 30;12:595811. doi: 10.3389/fimmu.2021.595811. eCollection 2021.
